Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

• Published in: Hepatology international Vol. 15; no. 6; pp. 1431 - 1441
• Main Authors: Shi, Ming, Li, Yuan-Yuan, Xu, Ruo-Nan, Meng, Fan-Ping, Yu, Shuang-Jie, Fu, Jun-Liang, Hu, Jin-Hua, Li, Jing-Xin, Wang, Li-Feng, Jin, Lei, Wang, Fu-Sheng
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.12.2021; Springer Nature B.V
• Subjects: Bilirubin; Cell therapy; Cholinesterase; Cirrhosis; Colorectal Surgery; Complications; Follow-Up Studies; Health services; Hepatocellular carcinoma; Hepatocytes; Hepatology; Humans; Liver; Liver cancer; Liver cirrhosis; Liver Cirrhosis - therapy; Medicine; Medicine & Public Health; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Original; Original Article; Patients; Prospective Studies; Prothrombin; Serum albumin; Side effects; Stem cells; Surgery; Survival; Treatment Outcome; Umbilical cord; Long-term survival; Liver function; Adverse events; HBV infection; Decompensated liver cirrhosis; Clinical trial; Prospective open-labeled study; Umbilical cord; Randomized controlled study; Mesenchymal stem cells

Background Mesenchymal stem cell (MSC) infusion was reported to improve liver function in patients with decompensated liver cirrhosis (DLC); however, whether the medication can improve outcome of these patients is poorly understood. Methods This prospective, open-labeled, randomized controlled study...